NO20040353L - Ny terapeutsk metode - Google Patents

Ny terapeutsk metode

Info

Publication number
NO20040353L
NO20040353L NO20040353A NO20040353A NO20040353L NO 20040353 L NO20040353 L NO 20040353L NO 20040353 A NO20040353 A NO 20040353A NO 20040353 A NO20040353 A NO 20040353A NO 20040353 L NO20040353 L NO 20040353L
Authority
NO
Norway
Prior art keywords
therapeutic method
new therapeutic
new
therapeutic
Prior art date
Application number
NO20040353A
Other languages
English (en)
Inventor
Richard Graham Knowles
Peter Ward
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20040353L publication Critical patent/NO20040353L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20040353A 2001-07-27 2004-01-26 Ny terapeutsk metode NO20040353L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0118373.0A GB0118373D0 (en) 2001-07-27 2001-07-27 Novel therapeutic method
PCT/EP2002/008322 WO2003011274A2 (en) 2001-07-27 2002-07-25 Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma

Publications (1)

Publication Number Publication Date
NO20040353L true NO20040353L (no) 2004-03-26

Family

ID=9919332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040353A NO20040353L (no) 2001-07-27 2004-01-26 Ny terapeutsk metode

Country Status (18)

Country Link
US (1) US20040180918A1 (no)
EP (1) EP1411914A2 (no)
JP (1) JP2004538302A (no)
KR (1) KR20040029384A (no)
CN (1) CN1551763A (no)
AR (1) AR034900A1 (no)
BR (1) BR0211450A (no)
CA (1) CA2455520A1 (no)
CO (1) CO5550426A2 (no)
GB (1) GB0118373D0 (no)
HU (1) HUP0401614A2 (no)
IL (1) IL160017A0 (no)
MX (1) MXPA04000793A (no)
NO (1) NO20040353L (no)
PL (1) PL368585A1 (no)
RU (1) RU2004105865A (no)
WO (1) WO2003011274A2 (no)
ZA (1) ZA200400410B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
PT1610787E (pt) * 2003-03-28 2008-04-23 Nycomed Gmbh Associação sinérgica compreendendo roflumilast e um agente anticolinérgico seleccionado de sais de tiotrópio para o tratamento de doenças respiratórias
US20060189642A1 (en) * 2003-03-28 2006-08-24 Altana Pharma Ag Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
TWI328009B (en) 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
EP1504756A1 (en) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Medicament compositions comprising a heterocyclic compound and an anticholinergic
CA2550848C (en) * 2004-02-06 2013-02-26 Meda Pharma Gmbh & Co. Kg Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
SI1713473T1 (sl) 2004-02-06 2013-06-28 Meda Pharma Gmbh & Co. Kg Kombinacija antiholinergikov in glukokortikoidov za dolgotranjno zdravljenje astme in KOPB
CA2552458A1 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
WO2005102344A1 (ja) * 2004-04-27 2005-11-03 Kyowa Hakko Kogyo Co., Ltd. 医薬組成物
EP1616567A1 (en) * 2004-07-16 2006-01-18 Boehringer Ingelheim Pharma GmbH & Co.KG Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts
HUE027076T2 (en) 2005-03-16 2016-08-29 Meda Pharma Gmbh & Co Kg Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
GB0521563D0 (en) 2005-10-21 2005-11-30 Glaxo Group Ltd Novel compounds
CN101321539B (zh) 2005-12-21 2010-09-29 Meda制药有限及两合公司 用于治疗炎性疾病的抗胆碱能药、糖皮质激素、β2-激动剂、PDE4抑制剂和抗白细胞三烯药的组合
PT2046787E (pt) 2006-08-01 2011-06-15 Glaxo Group Ltd Compostos de pirazolo[3,4-b]piridina e sua utilização como inibidores de pde4
KR20100014565A (ko) * 2007-04-11 2010-02-10 알콘 리서치, 리미티드 알레르기성 비염 및 알레르기성 결막염을 치료하기 위한 ｔｎｆａ의 억제제 및 항히스타민의 용도
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
WO2010097248A1 (en) 2009-01-13 2010-09-02 Glaxo Group Limited Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
CA2773483A1 (en) * 2009-10-01 2011-04-07 Alcon Research, Ltd. Olopatadine compositions and uses thereof
WO2012025474A1 (en) 2010-08-24 2012-03-01 Glaxo Group Limited Indazole compounds
WO2012025473A1 (en) 2010-08-24 2012-03-01 Glaxo Group Limited Cc.chemokine receptor 4 antagonists
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
ES2638850T3 (es) 2013-02-19 2017-10-24 Pfizer Inc. Compuestos de azabenzimidazol como inhibidores de las isoenzimas de la PDE4 para el tratamiento de trastornos del SNC y otros trastornos
WO2016012896A1 (en) 2014-07-24 2016-01-28 Pfizer Inc. Pyrazolopyrimidine compounds
SG11201700243YA (en) 2014-08-06 2017-02-27 Pfizer Imidazopyridazine compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000198734A (ja) * 1998-12-30 2000-07-18 Pfizer Inc 胃運動性減弱および関連疾患の治療のための運動性増強薬
EA004885B1 (ru) * 2000-01-31 2004-08-26 Пфайзер Продактс Инк. Никотинамидные бензоконденсированные гетероциклические производные, полезные в качестве селективных ингибиторов pde4-изозимов
WO2001070746A1 (fr) * 2000-03-23 2001-09-27 Takeda Chemical Industries, Ltd. Derives de furoisoquinoleine, leur procede de production et leur utilisation
US20020052312A1 (en) * 2000-05-30 2002-05-02 Reiss Theodore F. Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists
AR029984A1 (es) * 2000-07-27 2003-07-23 Smithkline Beecham Corp Metodo para reducir las exacerbaciones asociadas copd ambito
DE10110772A1 (de) * 2001-03-07 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
UA75626C2 (en) * 2000-12-28 2006-05-15 Almirall Prodesfarma Ag Quinuclidine derivatives and medicinal compositions containing the same

Also Published As

Publication number Publication date
AR034900A1 (es) 2004-03-24
CN1551763A (zh) 2004-12-01
RU2004105865A (ru) 2005-02-20
GB0118373D0 (en) 2001-09-19
WO2003011274A3 (en) 2003-09-18
KR20040029384A (ko) 2004-04-06
PL368585A1 (en) 2005-04-04
MXPA04000793A (es) 2004-05-21
EP1411914A2 (en) 2004-04-28
BR0211450A (pt) 2004-07-20
CA2455520A1 (en) 2003-02-13
HUP0401614A2 (hu) 2004-11-29
CO5550426A2 (es) 2005-08-31
JP2004538302A (ja) 2004-12-24
ZA200400410B (en) 2004-10-13
US20040180918A1 (en) 2004-09-16
IL160017A0 (en) 2004-06-20
WO2003011274A2 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
NO20040353L (no) Ny terapeutsk metode
NO20035156L (no) Fremgangsmåter for brønnbehandling
NO20035121D0 (no) Ny anvendelse
NO20033205D0 (no) Terapeutiske kromanforbindelser
DE60208982D1 (de) Fussbad
NO20014597D0 (no) Fremgangsmåte
DE10197149T1 (de) Anti-Zusetz-Behandlungen
NO20043664L (no) Ny fremgangsmate
NO20033919D0 (no) Ny anvendelse
DE60226093D1 (de) Urmedium-Reinigungsmethode
DE60208612D1 (de) Herzschrittmacher
ITMO20010226A0 (it) Apparato
FI20011252A0 (fi) Rakennusmenetelmä
SE0104471D0 (sv) New method
SE0104227D0 (sv) New method
SE0103573D0 (sv) New method
SE0103416D0 (sv) New method
SE0103357D0 (sv) New method
SE0201055D0 (sv) New method
DE60229385D1 (de) Herzschrittmacher
SE0100899D0 (sv) Method
SE0101479D0 (sv) Method
SE0102004D0 (sv) Indiviva-metoden
DOP2001000312A (es) Metodo
SE0100900D0 (sv) Method

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application